Zobrazeno 1 - 5
of 5
pro vyhledávání: '"D S, Battleman"'
Publikováno v:
International Journal of Clinical Practice. 59:1441-1451
Summary The MEDLINE database was searched from 1972 to June 2002 to identify studies of interventions designed to improve compliance with antihypertensive or lipid-lowering medications. Studies were required to employ a controlled design, follow pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ee71581fd58c80c7457ee7443dc1322
https://doi.org/10.1111/j.1368-5031.2005.00704.x
https://doi.org/10.1111/j.1368-5031.2005.00704.x
Publikováno v:
International journal of clinical practice. 59(12)
The MEDLINE database was searched from 1972 to June 2002 to identify studies of interventions designed to improve compliance with antihypertensive or lipid-lowering medications. Studies were required to employ a controlled design, follow patients for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b103ce55432312c81ca2e2e49b576a6a
https://pubmed.ncbi.nlm.nih.gov/16351677
https://pubmed.ncbi.nlm.nih.gov/16351677
Publikováno v:
Surgical technology international. 5
Interventional cardiology has undergone exciting changes since the first percutaneous transluminal coro-_ nary angioplasty was performed by Andreas Gruentzig in 1977.' Over the last several years, a variety of techniques have been developed which pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::026a08ad2d5025bf5dbf14cd639e1661
https://pubmed.ncbi.nlm.nih.gov/15858753
https://pubmed.ncbi.nlm.nih.gov/15858753
Publikováno v:
International review of cytology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::48c182bd4a0db9df4557527c6f38fd76
https://pubmed.ncbi.nlm.nih.gov/1478819
https://pubmed.ncbi.nlm.nih.gov/1478819
Publikováno v:
Journal of Clinical Oncology. 24:17549-17549
17549 Background: Bortezomib (VELCADE; Vc) has emerged as the standard of care for patients with relapsed or refractory multiple myeloma (MM). However, following initial Vc therapy, its utility in recurrent disease is unclear. This retrospective case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35bd608e7b6ab899c1179eb5c631e499
https://doi.org/10.1200/jco.2006.24.18_suppl.17549
https://doi.org/10.1200/jco.2006.24.18_suppl.17549